Secondary mutations at I1171 in the ALK gene confer resistance to both crizotinib and alectinib

Gouji Toyokawa; Fumihiko Hirai; Eiko Inamasu; Tsukihisa Yoshida; Kaname Nosaki; Tomoyoshi Takenaka; Masafumi Yamaguchi; Takashi Seto; Mitsuhiro Takenoyama; Yukito Ichinose

doi:10.1097/JTO.0000000000000358

Secondary mutations at I1171 in the ALK gene confer resistance to both crizotinib and alectinib

Gouji Toyokawa, Fumihiko Hirai, Eiko Inamasu, Tsukihisa Yoshida, Kaname Nosaki, Tomoyoshi Takenaka, Masafumi Yamaguchi, Takashi Seto, Mitsuhiro Takenoyama, Yukito Ichinose

Research output: Contribution to journal › Article › peer-review

48 Citations (Scopus)

Original language	English
Pages (from-to)	e86-e87
Journal	Journal of Thoracic Oncology
Volume	9
Issue number	12
DOIs	https://doi.org/10.1097/JTO.0000000000000358
Publication status	Published - 2014

All Science Journal Classification (ASJC) codes

Oncology
Pulmonary and Respiratory Medicine

Access to Document

10.1097/JTO.0000000000000358

Cite this

Secondary mutations at I1171 in the ALK gene confer resistance to both crizotinib and alectinib. / Toyokawa, Gouji; Hirai, Fumihiko; Inamasu, Eiko; Yoshida, Tsukihisa; Nosaki, Kaname; Takenaka, Tomoyoshi; Yamaguchi, Masafumi; Seto, Takashi; Takenoyama, Mitsuhiro; Ichinose, Yukito.

In: Journal of Thoracic Oncology, Vol. 9, No. 12, 2014, p. e86-e87.

Research output: Contribution to journal › Article › peer-review

@article{3110fc26ef3c42f387472a07af929fdd,

title = "Secondary mutations at I1171 in the ALK gene confer resistance to both crizotinib and alectinib",

author = "Gouji Toyokawa and Fumihiko Hirai and Eiko Inamasu and Tsukihisa Yoshida and Kaname Nosaki and Tomoyoshi Takenaka and Masafumi Yamaguchi and Takashi Seto and Mitsuhiro Takenoyama and Yukito Ichinose",

year = "2014",

doi = "10.1097/JTO.0000000000000358",

language = "English",

volume = "9",

pages = "e86--e87",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "International Association for the Study of Lung Cancer",

number = "12",

}

TY - JOUR

T1 - Secondary mutations at I1171 in the ALK gene confer resistance to both crizotinib and alectinib

AU - Toyokawa, Gouji

AU - Hirai, Fumihiko

AU - Inamasu, Eiko

AU - Yoshida, Tsukihisa

AU - Nosaki, Kaname

AU - Takenaka, Tomoyoshi

AU - Yamaguchi, Masafumi

AU - Seto, Takashi

AU - Takenoyama, Mitsuhiro

AU - Ichinose, Yukito

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84926421984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926421984&partnerID=8YFLogxK

U2 - 10.1097/JTO.0000000000000358

DO - 10.1097/JTO.0000000000000358

M3 - Article

C2 - 25393798

AN - SCOPUS:84926421984

VL - 9

SP - e86-e87

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 12

ER -

Secondary mutations at I1171 in the ALK gene confer resistance to both crizotinib and alectinib

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this